Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13

Jianzhang Yang, Yu Chang, Jean C. Tien, Zhen Wang, Yang Zhou, Pujuan Zhang, Weixue Huang, Josh N. Vo, Ingrid J. Apel, Cynthia Wang,

Journal of Medicinal Chemistry · 2022 · 73 citations · 37 references

DOIFull text

Open access

Concepts

Abstract

, suggesting the potential advantage of a CDK12/13 degrader for TNBC targeted therapy.

References

37